As a result of the passage of the NIH Reform Act of 2006, all research grant applications, regardless of cost, must undergo secondary review by the National Advisory Council prior to making an award. The requirement for Council review means that conference grant (R13) applications must be submitted far enough in advance to allow the award to be made prior to the conference meeting date.
The NHLBI will only support conferences that are critical to the mission of NHLBI (i.e., meetings directly related to heart, lung, blood, and/or sleep disorders and conditions). Meetings for the purpose of professional development (e.g., continuing medical education [CME]) are not supported through the R13 award mechanism. Supported meetings generally explore and identify: (a) critical gaps in knowledge; (b) research challenges and opportunities; and/or (c) promising strategies for advancing prevention, diagnosis and/or treatment modalities for science related to the NHLBI mission.
Support of conferences is contingent on the fiscal and programmatic interests and priorities of the NHLBI. Therefore, advance permission to submit an application (i.e., a Permission-to-Submit letter) is required for all conference grant and cooperative agreement applications, including new, resubmission, and revision applications. Potential applicants are urged to initiate contact (see NIH Contacts List) well in advance of the chosen application receipt date and at least six weeks before that date (see table below). Please note that agreement to accept an application does not guarantee funding.
Conference grants must be awarded prior to the meeting date. Consequently, the potential applicant must choose an application receipt date that allows for an award to be made prior to the meeting. The following table shows the deadline for the Request-to-Submit letter and the application receipt date necessary for the NHLBI to provide timely support for a conference. Conference grant (R13) applications must be submitted electronically through grants.gov.
|Request to Submit Date||Receipt Date||Approximate Review Date||Council Date||Conference Meeting Date|
|March 1||April 12||June/July||October||November through February|
|July 1||August 12||October/November||January||March through June|
|October 31||December 12||February/March||May||July through October|
The conference grant (R13) pre-submission process is coordinated by the NHLBI R13 Coordinator in the Division of Extramural Research Activities, Office of Extramural Policy and Training (DERA/OEPT). Permission to submit a conference grant application must be requested from the NHLBI R13 Coordinator (via a Request-to-Submit letter) at least six weeks before the application receipt date (see table above).
As part of the NHLBI submission request, the following information must be provided in the Request-to-Submit letter:
Typically, an NHLBI decision on willingness to accept primary assignment for a R13 conference grant can be expected within two weeks of submission of the Request-to-Submit letter.
At time of application submission, the signed Permission-to-Submit letter from the NHLBI must be attached to the cover letter of the R13 application, which should also identify all NIH ICs that may have interest in providing co-funding support.
Applications approved for funding may receive a Notice of Award within a few weeks after Council review. Other ICs interested in contributing funds to conference grant applications with NHLBI primary assignment must have: 1) a dual assignment on the application and 2) completed their respective funding approval processes prior to submitting co-funding agreements to the NHLBI. In order for the NHLBI to co-fund another IC’s application, the NHLBI must have been dually assigned to the application.
For important information on the conference grant (R13) mechanism, prospective applicants should review:
Institutional contacts for additional information regarding conference grant applications can be found at NIH Support for Conferences and Scientific Meetings (Parent R13/U13)